EpiPen Drug Company Under Scrutiny After Price Increase
Mylan Pharmaceuticals' CEO had a modest base salary in 2015, but her total compensation was in the multimillions.By Stephanie Liebergen | August 24, 2016
With the rising cost of EpiPens making headlines, people are turning their attention to the pharmaceutical company Mylan and its CEO, Heather Bresch.
So how much money does the company make? For the 2015 fiscal year, Mylan took in $9.45 billion in adjusted total revenue. The specialty segment of its business, which includes the EpiPen, had net sales of $1.2 billion.
As the head of the company, Bresch made a pretty penny in 2015. Her base salary is relatively modest at a little over $1.3 million, but when you factor in other perks and earnings options, her total compensation for 2015 was almost $19 million.